Insider transactions

Nadav Friedmann

CIK 1245267 · Chief Medical Officer · last filed 2022-10-03

"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.

Loading insider history…
Disclosed Exposure
$0
Companies
2
Total Filings
48
Lifetime Open-Market Net
-$737.0K

Charts

Trading activity, where the exposure sits, and each trade against the stock price.

PTIE price and trades

Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.

Shares held

Shares owned after each reported transaction on this company (direct holdings as reported).

Open-market buying and selling

by month

Dollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.

Exposure by company

latest
OfficerDirector10% owner* stale (no filing in 3 yrs)

Most recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.

Holdings By Company

Latest on-record share count from this person's most recent non-derivative Form 4 transaction in each company. Disclosed exposure = shares × current underlying price.
Symbol Role Shares Price Disclosed Exposure Lifetime OM Net Filings Latest Filed
CASSAVA SCIENCES INC (SAVA) Delisted Chief Medical Officer 112,074 $2.34 $262.7K $0 4 2022-10-03
CASSAVA SCIENCES INC (PTIE) Delisted Chief Sientific Officer 64,270 — — -$737.0K 44 2018-09-18

Recent Filings · Page 4 of 5

48 filings
Insider activity across all companies, newest first. Form 4 rows are post-trade confirmations (buys, sells, grants, exercises). Notice (144) rows are pre-trade notices of intent to sell restricted or control stock under Rule 144 — they may not all execute. Compare adjacent dates to see which notices became actual sales.
Filed Symbol Action Net Shares Net $ Link
2010-04-02 CASSAVA SCIENCES INC (PTIE) Delisted Sell (S) −15,000 -$92.6K EDGAR
2010-01-22 CASSAVA SCIENCES INC (PTIE) Delisted Other (J) +14,937 $0 EDGAR
2009-12-08 CASSAVA SCIENCES INC (PTIE) Delisted Buy (P) −15,000 -$77.8K EDGAR
2009-11-16 CASSAVA SCIENCES INC (PTIE) Delisted Sell (S) −15,000 -$75.0K EDGAR
2009-08-04 CASSAVA SCIENCES INC (PTIE) Delisted Grant (A) — $0 EDGAR
2009-05-11 CASSAVA SCIENCES INC (PTIE) Delisted Buy (P) +3,374 $12.7K EDGAR
2008-09-16 CASSAVA SCIENCES INC (PTIE) Delisted Other (J) +80,312 $687.5K EDGAR
2008-08-04 CASSAVA SCIENCES INC (PTIE) Delisted Buy (P) +25,000 $0 EDGAR
2008-06-17 CASSAVA SCIENCES INC (PTIE) Delisted Grant (A) — $0 EDGAR
2008-05-02 CASSAVA SCIENCES INC (PTIE) Delisted Buy (P) +3,267 $20.6K EDGAR
Showing 31–40 of 48
Page 4 of 5
Form 4 codes: P = open-market purchase · S = open-market sale · A = grant/award · M = option exercise · F = tax withholding at vest · G = bona-fide gift · D = disposition to issuer · J = other (see filing footnote). Only P / S codes carry directional signal.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes; missing follow-up Form 4s suggest the notice was cancelled or modified.